Santa Cruz Biotechnology offers a broad range of HIV-2 gp36 monoclonal antibodies supporting research in understanding the complexities of HIV-2 infection. HIV-2 gp36 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HIV-2 gp36 is a glycoprotein that plays a crucial role in the viral life cycle, facilitating the entry of the virus into host cells. Understanding HIV-2 gp36 function is essential for developing therapeutic strategies and vaccines against HIV-2, which remains a significant public health concern in certain regions. The study of HIV-2 gp36 can provide insights into the mechanisms of viral evasion and persistence. Research focused on HIV-2 gp36 continues to reveal new aspects of viral infection and host cell interactions. Investigating HIV-2 gp36 helps advance our knowledge of viral entry mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for HIV-2 gp36 enable researchers worldwide to advance scientific understanding of HIV-2 infection and contribute to potential therapeutic developments.